Addressing Cryptosporidium Infection Among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality

Overview

Journal PLoS Negl Trop Dis

Specialties Infectious Diseases
Tropical Medicine

Date 2016 Jan 29

PMID 26820408

Citations 16

Authors

David A Shoultz

Eugenio L de Hostos

Robert K M Choy

Affiliations

Soon will be listed here.

Citing Articles

Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.

Gattan H, Fouad S, Ellisy R, Elshazly H, El-Kady A J Parasit Dis. 2024; 48(2):370-380.

PMID: 38840881 PMC: 11147982. DOI: 10.1007/s12639-024-01676-0.

and evaluation of the anti-cryptosporidial activity of eugenol.

Gattan H, Wakid M, Qahwaji R, Altwaim S, Mahjoub H, Alfaifi M Front Vet Sci. 2024; 11:1374116.

PMID: 38515537 PMC: 10954888. DOI: 10.3389/fvets.2024.1374116.

Newly fabricated zinc oxide nanoparticles loaded materials for therapeutic nano delivery in experimental cryptosporidiosis.

Hamdy D, Ismail M, El-Askary H, Abdel-Tawab H, Ahmed M, Fouad F Sci Rep. 2023; 13(1):19650.

PMID: 37949873 PMC: 10638360. DOI: 10.1038/s41598-023-46260-3.

On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target.

Yang B, Yan Y, Wang D, Zhang Y, Yin J, Zhu G PLoS Negl Trop Dis. 2023; 17(3):e0011217.

PMID: 36972284 PMC: 10079235. DOI: 10.1371/journal.pntd.0011217.

A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: A case-case-control study in Ethiopian children.

Johansen O, Abdissa A, Zangenberg M, Mekonnen Z, Eshetu B, Sharew B PLoS Negl Trop Dis. 2022; 16(6):e0010508.

PMID: 35666717 PMC: 9203008. DOI: 10.1371/journal.pntd.0010508.

References

Ryan U, Hijjawi N . New developments in Cryptosporidium research. Int J Parasitol. 2015; 45(6):367-73. DOI: 10.1016/j.ijpara.2015.01.009. View

Zwisler G, Simpson E, Moodley M . Treatment of diarrhea in young children: results from surveys on the perception and use of oral rehydration solutions, antibiotics, and other therapies in India and Kenya. J Glob Health. 2013; 3(1):010403. PMC: 3700033. DOI: 10.7189/jogh.03.010403. View

Tzipori S, Smith M, Birch C, Barnes G, Bishop R . Cryptosporidiosis in hospital patients with gastroenteritis. Am J Trop Med Hyg. 1983; 32(5):931-4. DOI: 10.4269/ajtmh.1983.32.931. View

Bessoff K, Sateriale A, Lee K, Huston C . Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother. 2013; 57(4):1804-14. PMC: 3623326. DOI: 10.1128/AAC.02460-12. View

Lang D . Opportunities to assess factors contributing to the development of the intestinal microbiota in infants living in developing countries. Microb Ecol Health Dis. 2015; 26:28316. PMC: 4451096. DOI: 10.3402/mehd.v26.28316. View

Legrand F, Grenouillet F, Larosa F, Dalle F, Saas P, Millon L . Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study. Bone Marrow Transplant. 2010; 46(6):858-62. DOI: 10.1038/bmt.2010.200. View

Rossignol J, Ayoub A, Ayers M . Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001; 184(1):103-6. DOI: 10.1086/321008. View

de Hostos E, Choy R, Nguyen T . Developing novel antisecretory drugs to treat infectious diarrhea. Future Med Chem. 2011; 3(10):1317-25. DOI: 10.4155/fmc.11.87. View

Guerrant D, Moore S, Lima A, Patrick P, Schorling J, Guerrant R . Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg. 1999; 61(5):707-13. DOI: 10.4269/ajtmh.1999.61.707. View

10.

Kotloff K, Nataro J, Blackwelder W, Nasrin D, Farag T, Panchalingam S . Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013; 382(9888):209-22. DOI: 10.1016/S0140-6736(13)60844-2. View

11.

Bessoff K, Spangenberg T, Foderaro J, Jumani R, Ward G, Huston C . Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box. Antimicrob Agents Chemother. 2014; 58(5):2731-9. PMC: 3993250. DOI: 10.1128/AAC.02641-13. View

12.

Sonzogni-Desautels K, Renteria A, Camargo F, Di Lenardo T, Mikhail A, Arrowood M . Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Front Microbiol. 2015; 6:973. PMC: 4585137. DOI: 10.3389/fmicb.2015.00973. View

13.

Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M . High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009; 9:195. PMC: 2794874. DOI: 10.1186/1471-2334-9-195. View

14.

Abubakar I, Aliyu S, Arumugam C, Usman N, Hunter P . Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol. 2007; 63(4):387-93. PMC: 2203234. DOI: 10.1111/j.1365-2125.2007.02873.x. View

15.

Rossignol J, Kabil S, El-Gohary Y, Younis A . Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. 2006; 4(3):320-4. DOI: 10.1016/j.cgh.2005.12.020. View

16.

Casemore D, Sands R, Curry A . Cryptosporidium species a "new" human pathogen. J Clin Pathol. 1985; 38(12):1321-36. PMC: 499487. DOI: 10.1136/jcp.38.12.1321. View

17.

Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A . Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002; 360(9343):1375-80. DOI: 10.1016/S0140-6736(02)11401-2. View

18.

Agnew D, Lima A, Newman R, Wuhib T, Moore R, Guerrant R . Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis. 1998; 177(3):754-60. DOI: 10.1086/514247. View

19.

Alcantara C, Yang C, Steiner T, Barrett L, Lima A, Chappell C . Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am J Trop Med Hyg. 2003; 68(3):325-8. View

20.

Egger M, Mausezahl D, Odermatt P, Marti H, Tanner M . Symptoms and transmission of intestinal cryptosporidiosis. Arch Dis Child. 1990; 65(4):445-7. PMC: 1792199. DOI: 10.1136/adc.65.4.445. View